# A Study of Adjuvant Melanoma Stakeholder Treatment Preferences

> **NCT05115006** · — · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 294 (actual)

## Conditions studied

- Melanoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05115006
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-07
- **Primary completion:** 2022-06-02
- **Final completion:** 2022-06-02
- **Target enrollment:** 294 (ACTUAL)
- **Last updated:** 2022-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05115006

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05115006, "A Study of Adjuvant Melanoma Stakeholder Treatment Preferences". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05115006. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*